1982
DOI: 10.1111/j.1365-2141.1982.tb07290.x
|View full text |Cite
|
Sign up to set email alerts
|

Atypical cobalamin binding in the serum of congenital deficiency of transcobalamin II

Abstract: The serum cobalamin (Cb 1) binding patterns were described in nine children with congenital deficiency of transcobalamin II (TC II). Immunoreactive TC II was less than 100 pg/ml TC II-Cb 1 equivalent in eight and 150 pg/ml in the ninth. There was neither endogenous TC II-Cb 1 (holo TC II) nor apo TC II. Thus, the defect was characterized by the absence of any binding of Cb 1 to TC II either in vivo or in vitro and either non-detectable or much reduced immunoreactive TC II. Only the serum from an untreated infa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
5
0

Year Published

1984
1984
2014
2014

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 12 publications
1
5
0
Order By: Relevance
“…Five grams of Hydroxocobalamin, corresponding to 10 6 times the recommended daily intake, can drop the concentration of soluble H 2 S to almost zero during infusion of moderate to severe levels of H 2 S infusion (4). This observation supports the view that Hydroxocobalamin or other Vitamin B12 analogues (11), could exert a protective effect against H 2 S toxicity since not only can they diffuse within cells (12) via non-transcobalamin mechanisms (13–15), but they also oppose the effects of Nitric oxide (1619), recently shown to potentiate the effects of H 2 S (20, 21). Finally, intravenous infusion of large dose of Hydroxocobalamin is already FDA approved for the treatment of cyanide poisoning (22, 23).…”
Section: Introductionsupporting
confidence: 86%
“…Five grams of Hydroxocobalamin, corresponding to 10 6 times the recommended daily intake, can drop the concentration of soluble H 2 S to almost zero during infusion of moderate to severe levels of H 2 S infusion (4). This observation supports the view that Hydroxocobalamin or other Vitamin B12 analogues (11), could exert a protective effect against H 2 S toxicity since not only can they diffuse within cells (12) via non-transcobalamin mechanisms (13–15), but they also oppose the effects of Nitric oxide (1619), recently shown to potentiate the effects of H 2 S (20, 21). Finally, intravenous infusion of large dose of Hydroxocobalamin is already FDA approved for the treatment of cyanide poisoning (22, 23).…”
Section: Introductionsupporting
confidence: 86%
“…Albumin in human serum may contain small amounts of endogenous Cbl, but it is difficult to accurately quantify in the presence of the Cbl bound to R and TCII. It is more easily identified in patients who lack R or TCII and after treatment with pharmacological doses of OH-Cbl (18)(19)(20). R-binder, TCII, and albumin differ greatly in their affinities for OH-Cbl (4, 2 1).…”
Section: Discussionmentioning
confidence: 99%
“…Case I: B.A., ~--Clinical details of this TC II-deficient patient have been described extensively (Hitzig et al, 1974;Hall et al, 1979;Frfiter-Schr6der et al, 1981). Impairment of haematopoietic function, defective antibody synthesis and agammaglobulinaemia were correctable with vitamin Blz administration.…”
Section: Methods and Patientsmentioning
confidence: 95%
“…Reduced TC II serum levels in healthy relatives and tack of apo-and holo-TC II in the TC II-deficient patient (Hall et at., 1979) indicate that congenital deficiency is inherited as an autosomal recessive trait. TC II can be split up into isoproteins by polyacrylamide gel electrophoresis (Fr~tter-Schr6der et al, 1979a).…”
mentioning
confidence: 96%